Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence

NCT: NCT05739331 · RECRUITING

NCT IDNCT05739331
StatusRECRUITING
Start Date2023-05-01
Completion2027-12-01
SponsorNorwegian University of Science and Technology (OTHER)
First posted
Last updated

Brief Summary

To evaluate the usefulness of Deep neural network (DNN) in the evaluation of mediastinal and hilar lymph nodes with Endobronchial ultrasound (EBUS). The study will explore the feasibility of DNN to identify lymph nodes and blood vessel examined with EBUS.

Frequently Asked Questions

What is Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence?

Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence is a clinical trial registered under NCT05739331. Current status: RECRUITING.

What is the status of NCT05739331?

The current status of NCT05739331 (Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence) is: RECRUITING.

When did Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence start?

Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence started on 2023-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑